Simplifying Data Collection In Lupus Clinical Studies

Systemic Lupus Erythematosus (SLE) is an autoimmune disease that causes inflammation and tissue damage in the skin, joints, kidneys, lungs, blood vessels, and brain. Often characterized by an aggregate of symptoms due to its unpredictability, hosting screenings and gathering data in lupus studies can be very difficult and complex. In clinical trials, lupus research often calls for the utilization of multiple assessments with different scoring criteria, and as a result, must also follow detailed protocols.
The Electronic Lupus Assessment Suite® (eLAS®) is designed to engage patients through straightforward, efficient, and reliable direct data capture (DDC), eliminating manual activities and errors associated with traditional paper methods. Discover how this fit-for-purpose solution with DDC can improve any clinical trial execution, produce cleaner data, and ensure compliance and protocol adherence.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.